Our Therapies

ONPATTRO® Infusion Therapy

ONPATTRO® (patisiran) is a small interfering RNA (siRNA) therapeutic indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. This medication reduces the production of TTR protein through RNA interference and is administered as an intravenous infusion once every 3 weeks.

Meet our Infusion Specialists

  • Natali Craig

    Natali Craig

    Product Designer

  • Phoenix Baker

    Phoenix Baker

    Engineering Manager

  • Candice Wu

    Candice Wu

    Backend Developer

  • Lana Steiner

    Lana Steiner

    Product Manager

For Provider

Simplify patient referrals and offer advanced treatment options with our infusion partnership program.

For Patient

There may be a better way to manage your condition – explore infusion therapy.

logo

Cutting-edge infusion therapies and injections for patients with complex chronic conditions and rare diseases.

© 2024 violet health®: Infusion Care. All rights reserved.